November 10, 2020 Posted in Press Releases
Advanced clinical development of NVX‑CoV2373 with initiation of first Phase 3 trial to evaluate efficacy, safety and immunogenicity U.K. Phase 3 interim data expected as soon as early first quarter 2021 Secured additional large-scale manufacturing for NVX-CoV2373 with expected global capacity over two billion doses by mid-2021 Formed leadership team to advance NanoFlu through global […]Read MoreDaily Archives November 10, 2020
Advanced clinical development of NVX‑CoV2373 with initiation of first Phase 3 trial to evaluate efficacy, safety and immunogenicity U.K. Phase 3 interim data expected as soon as early first quarter 2021 Secured additional large-scale manufacturing for NVX-CoV2373 with expected global capacity over two billion doses by mid-2021 Formed leadership team to advance NanoFlu through global […]
MONTREAL, Nov. 09, 2020 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (“BRW” or the “Company”) is pleased to announce that the Board of Directors has appointed Robert Wares, currently Chairman, as Chief Executive Officer of the Company, and Killian Charles as President of the Company. Mr. Charles currently works for Osisko Metals Inc., a zinc development […]
SYDNEY - Australia has recorded another day of no locally transmitted coronavirus cases. Health authorities say there are now fewer than 90 active COVID-19 infections in the country. For three consecutive days, Australia has recorded no new cases of ...
JERUSALEM - Chief Palestinian negotiator Saeb Erekat died Tuesday of COVID-19 after weeks in an Israeli hospital. Palestinian Authority President Mahmoud Abbas declared three days of mourning for 65-year-old Erekat, who for decades was at the forefron...